{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T15:12:14Z","timestamp":1656774734024},"reference-count":11,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background: <\/jats:title>\n<jats:p>Prosopagnosia is a rare form of apraxia, in which a person has normal memory and vision, but has impaired cognition of human faces that are manifested through symptoms such as not being able to recognize the face of a familiar person, one has known or not being able to remember the face of a person. Here, we report the case of a patient with transient prosopagnosia associated with brain metastasis from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma who was treated with tyrosine kinase inhibitors (TKIs).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Case Description: <\/jats:title>\n<jats:p>A 52-year-old right-handed man with lung adenocarcinoma was introduced to our department because brain metastasis. On admission, he complained that he could not recognize his wife\u2019s face, but he could recall her face based on her voice. MRI revealed a right temporo-occipital enhancing lesion with perifocal edema and dissemination that were indicative of brain metastasis from lung adenocarcinoma. Two weeks after open biopsy, he was started on TKI therapy with osimertinib at a dosage of 80 mg\/day. An MRI scan taken 1 month later revealed shrinkage of the metastasis. In addition, he had recovered from transient prosopagnosia and returned to normal life.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>In this study, the TKI osimertinib was administered to a patient with brain metastasis of EGFR-mutated lung adenocarcinoma who presented with prosopagnosia, and the patient\u2019s lesion shrunk and his symptoms were reversed with this treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_500_2022","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T12:17:49Z","timestamp":1656677869000},"page":"280","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of transient prosopagnosia with a tyrosine kinase inhibitor in a case of brain metastasis from EGFR-mutated lung adenocarcinoma"],"prefix":"10.25259","volume":"13","author":[{"given":"Shigeto","family":"Soyama","sequence":"first","affiliation":[{"name":"Department of Medical Technology Center, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Hontsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Medical Technology Center, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Medical Technology Center, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Medical Technology Center, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kido","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nakase","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"10.25259\/SNI_500_2022\/ref-1","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1176\/appi.neuropsych.15070169","article-title":"Transient prosopagnosia with right temporal astrocytoma","volume":"28","author":"Anderson","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.25259\/SNI_500_2022\/ref-2","doi-asserted-by":"crossref","first-page":"756.e1","DOI":"10.1016\/j.wneu.2016.10.025","article-title":"Prosopagnosia induced by a left anterior temporal lobectomy following a right temporo-occipital resection in a multicentric diffuse low-grade glioma","volume":"97","author":"Corrivetti","year":"2017","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_500_2022\/ref-3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/EB.S92838","article-title":"Prosopagnosia: Current perspectives","volume":"8","author":"Corrow","year":"2016","journal-title":"Eye Brain"},{"key":"10.25259\/SNI_500_2022\/ref-4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0000000000008204","article-title":"Pearls and Oy-sters: Isolated prosopagnosia as the presenting complaint in glioblastoma: The face of deception","volume":"93","author":"Das","year":"2019","journal-title":"Neurology"},{"key":"10.25259\/SNI_500_2022\/ref-5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17470919.2014.959618","article-title":"Facial affect recognition linked to damage in specific white matter tracts in traumatic brain injury","volume":"10","author":"Genova","year":"2015","journal-title":"Soc Neurosci"},{"key":"10.25259\/SNI_500_2022\/ref-6","first-page":"2929782","article-title":"Transient dyschromatopsia, static form agnosia, and prosopagnosia observed in a patient with Anti-NMDA receptor encephalitis","volume":"2019","author":"Hashimoto","year":"2019","journal-title":"Case Rep Neurol Med"},{"key":"10.25259\/SNI_500_2022\/ref-7","doi-asserted-by":"crossref","first-page":"e0248785","DOI":"10.1371\/journal.pone.0248785","article-title":"Facial memory ability and self-awareness in patients with temporal lobe epilepsy after anterior temporal lobectomy","volume":"16","author":"Hosokawa","year":"2021","journal-title":"PLoS One"},{"key":"10.25259\/SNI_500_2022\/ref-8","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1523\/JNEUROSCI.17-11-04302.1997","article-title":"The fusiform face area: A module in human extrastriate cortex specialized for face perception","volume":"17","author":"Kanwisher","year":"1997","journal-title":"J Neurosci"},{"key":"10.25259\/SNI_500_2022\/ref-9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000203113.12324.57","article-title":"Transient prosopagnosia after ischemic stroke","volume":"66","author":"Lang","year":"2006","journal-title":"Neurology"},{"key":"10.25259\/SNI_500_2022\/ref-10","doi-asserted-by":"crossref","first-page":"e046451","DOI":"10.1136\/bmjopen-2020-046451","article-title":"Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): Study protocol of a multicentre, real-world observational study","volume":"12","author":"Watanabe","year":"2022","journal-title":"BMJ Open"},{"key":"10.25259\/SNI_500_2022\/ref-11","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.12998\/wjcc.v8.i24.6487","article-title":"Delayed diagnosis of prosopagnosia following a hemorrhagic stroke in an elderly man: A case report","volume":"8","author":"Yuan","year":"2020","journal-title":"World J Clin Cases"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/treatment-of-transient-prosopagnosia-with-a-tyrosine-kinase-inhibitor-in-a-case-of-brain-metastasis-from-egfr-mutated-lung-adenocarcinoma\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/treatment-of-transient-prosopagnosia-with-a-tyrosine-kinase-inhibitor-in-a-case-of-brain-metastasis-from-egfr-mutated-lung-adenocarcinoma\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T12:18:02Z","timestamp":1656677882000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/treatment-of-transient-prosopagnosia-with-a-tyrosine-kinase-inhibitor-in-a-case-of-brain-metastasis-from-egfr-mutated-lung-adenocarcinoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":11,"alternative-id":["10.25259\/SNI_500_2022"],"URL":"https:\/\/doi.org\/10.25259\/sni_500_2022","relation":{},"ISSN":["2152-7806"],"issn-type":[{"value":"2152-7806","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"280"}}